ANAHEIM, CA — A new trial shows the combination of aspirin plus ticagrelor (Brilinta, AstraZeneca) resulted in significant improvement in saphenous vein graft (SVG) patency at 12 months compared with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback